Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
about
βIII-Tubulin: biomarker of taxane resistance or drug target?Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.Growth and differentiation factor 3 induces expression of genes related to differentiation in a model of cancer stem cells and protects them from retinoic acid-induced apoptosis.Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer.Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.Correlation between microtubule-associated gene expression and chemosensitivity of patients with stage II non-small cell lung cancerMitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds.Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulationClass III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxelClass III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?High-level βIII-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome.Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells.Use of Integrated Computational Approaches in the Search for New Therapeutic Agents.Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer.
P2860
Q28284878-8B70AB65-4AB0-4486-B9FD-3EAD048E097DQ34313834-AB56A927-47BB-4195-A5C9-C03040C385AFQ34947381-4C7E0FEC-005A-430E-B32C-3AA7645B641FQ35929796-8CE36E10-9A05-4BBF-94CB-3F06304E891FQ36296731-8573EF4F-E396-4462-8D27-7813E1AB07B1Q36900849-B45F6CE0-6463-4F22-9314-9899D249042FQ37168749-B3563393-1A56-4EB3-98C2-D368561A2A03Q37240065-551ADD66-6027-4626-84F1-70BB61EDC669Q37376285-2853BFBB-F4DF-4109-A528-3E2068238412Q37625835-18499F6B-E306-4E53-A7D2-B55D55C1856CQ38069185-42F73B29-E026-4F72-AC26-232220A4AC01Q38667965-0BDB20E9-7DB3-4440-8CE4-D558ACD92BDDQ38835062-CE56357D-8A12-47D6-A63C-ECE6BEE70B7CQ38933291-9E13FF2F-F6A0-4F1D-BAFC-B55929F1E0C4Q50863694-D2154A48-C607-4239-B392-AB4B1A3006A1
P2860
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@ast
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@en
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@nl
type
label
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@ast
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@en
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@nl
prefLabel
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@ast
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@en
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@nl
P2093
P3181
P1476
Class III β-tubulin (TUBB3): more than a biomarker in solid tumors?
@en
P2093
P304
P3181
P356
10.2174/156652411798062368
P407
P577
2011-12-01T00:00:00Z